The loss of DAPK1 expression, mainly by hypermethylation of its promoter region, enhances the metastatic potential of cancer cells and has been proven to occur in a variety of cancers, including cancer of the uterine cervix [14], [24]. Here, DAPK1 is linked to cancer.